Records containing: Major Depressive Disorder
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study results posted · 2026-10-30SMART Trial to Predict Anhedonia Response to Antidepressant Treatment
-
CLINICAL_TRIALS study record update · 2026-10-30SMART Trial to Predict Anhedonia Response to Antidepressant Treatment
-
CLINICAL_TRIALS study record update · 2026-10-30The Mechanism of Action Underlying Ketamine's Antidepressant Effects: An Investigation of the AMPA Throughput Theory in Patients With Treatment-Resistant Major Depression
-
CLINICAL_TRIALS study record update · 2026-10-30Behavioral and Neuronal Correlates of Human Mood States
-
CLINICAL_TRIALS study record update · 2026-10-30Influence of Psychomotor Therapy on Quality of Life in Patients With a Major Depressive Disorder: a Randomized Controlled Trial
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study results posted · 2026-10-29An Open Label Study of Single-Dose Psilocybin for Major Depressive Disorder With Co-occurring Borderline Personality Disorder
-
CLINICAL_TRIALS study record update · 2026-10-29An Open Label Study of Single-Dose Psilocybin for Major Depressive Disorder With Co-occurring Borderline Personality Disorder
-
CLINICAL_TRIALS study record update · 2026-10-29Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2026-10-29A Randomized, Double-blind, Placebo-Controlled Phase 3 Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Once-Daily Oral Administration of Vortioxetine in Japanese Pediatric Patients 12 to 17 Years of Age With Major Depressive Disorder (MDD)
-
CLINICAL_TRIALS study record update · 2026-10-27A Phase III, Placebo-Controlled, Randomized, Double-Blind Trial of Oral Doses of CYB003 to Assess Combined Safety and Efficacy in Humans With Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2026-10-27Discovery and Validation of Digital Phenotypes for Predicting Recurrence of Depressive Episodes_Validation Set Collection
-
CLINICAL_TRIALS study record update · 2026-10-27Tracking Response to Antidepressants in Advance of Investigational Trials
-
CLINICAL_TRIALS study record update · 2026-10-27A Phase III, Placebo-Controlled, Randomized, Double-Blind Trial of Oral Doses of CYB003 to Assess Combined Safety and Efficacy in Humans With Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2026-10-26Defining Neurobiological Links Between Substance Use and Mental Illness
-
CLINICAL_TRIALS study record update · 2026-10-26A Randomized Clinical Trial of Response to Psychopharmacotherapy According to Multimodal Serum Biomarkers in Depressive Patients
-
CLINICAL_TRIALS study record update · 2026-10-26Study of Neuro-Cognitive Correlates of Pediatric Anxiety Disorders
-
CLINICAL_TRIALS study record update · 2026-10-26A Randomized, Double-Blind, Placebo-Controlled Study of ALTO-300 With an Open-Label Extension in Adults With Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2026-10-23A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled, 12-Week Study (Part A) With a 40-Week Open-label Extension (Part B) Evaluating the Efficacy and Safety of Oral DT120 Compared to Placebo in the Treatment of Adults With Major Depressive Disorder - Ascend
-
CLINICAL_TRIALS study record update · 2026-10-23NMDA Modulation in Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2026-10-23NMDA Modulation in Antidepressant Nonresponders With Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2026-10-13A Phase 3, Randomized, Double-blind, Placebo-Controlled, Multicenter Study to Evaluate Azetukalner in Moderate-to-Severe Major Depressive Disorder
-
CLINICAL_TRIALS study results posted · 2026-10-08Elucidating the Neurocircuitry of Irritability With High-Field Neuroimaging to Identify Novel
-
CLINICAL_TRIALS study results posted · 2026-09-29Randomized, Cross-over, Placebo-controlled Trial to Determine Target Engagement and Dose Response of Optimized Closed-loop rTMS for Medication-resistant Depression
-
CLINICAL_TRIALS study results posted · 2026-09-28Pilot Study Using Endogenous Aperiodic Brain Activity to Personalize Transcranial Alternating Current Stimulation as a Treatment for Antenatal Depression: PandA-tACS
-
CLINICAL_TRIALS study record update · 2026-09-28A Phase III, Placebo-Controlled, Randomized, Double-Blind Trial of Oral Doses of CYB003 to Assess Combined Safety and Efficacy in Humans With Major Depressive Disorder